Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Ozone therapy might improve cancer treatment and reduce its side effects.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Higher SFRP-4 levels were found in people without a diabetic family history.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.